A
$ Value
$0
Shares
6,610
Price
$0
Filed
May 22
Insider
Name
GORMAN KEVIN CHARLES
Title
—
CIK
0001201096
Roles
Director
Transaction Details
Transaction Date
2025-05-21
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
6,610
Footnotes
Option vests in 12 monthly installments beginning June 21, 2025.
Filing Info
GORMAN KEVIN CHARLES's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | F | $375K |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | F | $360K |
| 2026-02-13 | NBIX | A | $0 |
| 2026-02-13 | NBIX | F | $4.3M |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | M | $0 |
| 2026-01-31 | NBIX | M | $0 |
| 2026-01-31 | NBIX | F | $387K |
Other Insiders at NBIX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GORMAN KEVIN CHARLES | — | — | 2026-02-13 |
|
Lippoldt Darin
Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gano Kyle
Chief Executive Officer
|
— | — | 2026-02-13 |
|
BENEVICH ERIC
Chief Commercial Officer
|
— | — | 2026-02-13 |
|
ABERNETHY MATT
Chief Financial Officer
|
— | — | 2026-03-04 |
|
Cooke Julie
Chief Human Resources Officer
|
— | — | 2026-02-13 |
|
Keswani Sanjay Chandru
Chief Medical Officer
|
— | — | 2026-02-13 |
|
Onyia Jude
Chief Scientific Officer
|
— | — | 2026-02-20 |
|
Boyer David W.
Chief Corp. Affairs Officer
|
— | — | 2026-02-13 |
|
Delaet Ingrid
Chief Regulatory Officer
|
— | — | 2026-02-13 |